S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
LON:AVV

AVEVA Group (AVV) Share Price, News & Analysis

GBX 3,219
+3,186.81 (+9,900.00%)
(As of 01/18/2023)
Today's Range
3,219
3,219
50-Day Range
3,219
3,219
52-Week Range
1,800
3,305
Volume
N/A
Average Volume
2.99 million shs
Market Capitalization
£9.72 billion
P/E Ratio
N/A
Dividend Yield
0.01%
Price Target
N/A
AVV stock logo

About AVEVA Group Stock (LON:AVV)

AVEVA Group plc, through its subsidiaries, provides engineering and industrial software solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company offers engineering, procurement, and construction; asset performance management; monitoring and control; planning and scheduling; and operation and optimization industrial software solutions. It also provides digital transformation solutions covering artificial intelligence, cloud, digital twin, edge, extended reality, and Industrial Internet of Things products; and customer support and training services. The company serves customers in the chemicals, food and beverage, consumer packaged goods, infrastructure, life sciences, marine, mining, oil and gas, power and utilities, pulp and paper, steel fabrication, and water and wastewater industries. The company was founded in 1967 and is based in Cambridge, the United Kingdom. AVEVA Group plc is a subsidiary of Schneider Electric SE.

AVV Stock Price History

AVV Stock News Headlines

Schneider Electric confirms Bentley Systems talks
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Aveva Group Plc (LSE: AVV)
AVV.L Regulatory News
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
FTSE 100 lower as Bank of Japan's surprise move sparks fear
Aveva Group rises Wednesday, outperforms market
Dispatch of Addendum Letters to Participants in the AVEVA Share Plans
Form 8.3 - AVV LN Equity 13-November-22 Dealing Disclosure
Form 8.3 - AVV LN Equity 11-November-22 Dealing Disclosure
Dispatch of Letters to Participants in the AVEVA Share Plans
Schneider CFO says Aveva deal 'not an absolute must'
See More Headlines
Receive AVV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVEVA Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Software - Application
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
6,250
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.26 billion
Cash Flow
GBX 68 per share
Book Value
GBX 1,878.30 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.72 billion
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Peter W. Herweck (Age 56)
    CEO & Exec. Director
    Comp: $1.76M
  • Mr. James Kidd (Age 53)
    Chief Strategy & Transformation Officer and Exec. Director
    Comp: $920k
  • Mr. Brian DiBenedetto
    Chief Financial Officer
  • Mr. Caspar Herzberg
    COO & Chief Revenue Officer
  • Mr. Andrew McCloskey
    CTO and Exec. VP of R&D
  • Mr. Matthew Howard Springett
    Head of Investor Relations
  • Ms. Helen Louise Lamprell
    Gen. Counsel & Company Sec.
  • Mr. Nayef Bou Chaaya
    VP of Sales & Head of Middle East and Africa
  • Ms. Caoimhe Keogan (Age 45)
    Chief People Officer
  • Mr. Amish Sabharwal
    Exec. VP of Engineering Bus.

AVV Stock Analysis - Frequently Asked Questions

How have AVV shares performed in 2024?

AVEVA Group's stock was trading at GBX 3,219 at the start of the year. Since then, AVV stock has increased by 0.0% and is now trading at GBX 3,219.
View the best growth stocks for 2024 here
.

Is AVEVA Group a good dividend stock?

AVEVA Group (LON:AVV) pays an annual dividend of GBX 0.38 per share and currently has a dividend yield of 1.16%.
Read our dividend analysis for AVV.

What other stocks do shareholders of AVEVA Group own?
How do I buy shares of AVEVA Group?

Shares of AVV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AVV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners